A development of combination therapy for fibrotic diseases
The present invention relates to a combination composition of metformin and Chir99021 for the treatment of fibrosis. The composition according to the present invention inhibits collagen deposition, inhibits inflammatory response, prevents fibrosis of blood vessels, and prevents tissue damage, thereb...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
05.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a combination composition of metformin and Chir99021 for the treatment of fibrosis. The composition according to the present invention inhibits collagen deposition, inhibits inflammatory response, prevents fibrosis of blood vessels, and prevents tissue damage, thereby having an excellent preventive and therapeutic effect on fibrosis.
본 발명은 섬유증 치료를 위한 메트포민 및 Chir99021의 복합제 조성물에 관한 것이다. 본 발명에 따른 조성물은 콜라겐 침착을 억제하고, 염증 반응을 저해하며, 혈관의 섬유화를 방지하고, 조직 손상을 방지함으로써, 섬유증에 대해 우수한 예방 및 치료 효과를 가진다. |
---|---|
Bibliography: | Application Number: KR20200035320 |